Kevin Dennis
Family Medicine · Franklin, TNNPI 1740268861
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $353,184 of the $353,563 with a category attached, or 99.9%. CSL Behring accounts for 63.0% of it on its own, with 14 other manufacturers making up the rest. Reporting peaked in 2019 at $107,270 and has fallen 58.1% since, to $44,928 in 2025. Among family medicine clinicians in TN with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 483 payments — averaging $732.02 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- CSL Behring$223K
- Kedplasma LLC$78K
- CSL Plasma Inc.$53K
- GSK$76
- Hologic Sales And Service, LLC$56
- Exact Sciences$48
- plus $200 from 9 others
What the payments were for
- Consulting fees$353,184100%
- Food & beverage$3800%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| CSL Behring | 353 | $222,655 |
| Kedplasma LLC | 26 | $78,000 |
| CSL Plasma Inc. | 85 | $52,529 |
| GSK | 4 | $76 |
| Hologic Sales And Service, LLC | 2 | $56 |
| Exact Sciences | 3 | $48 |
| AbbVie | 2 | $43 |
| Averitas Pharma Inc. | 1 | $33 |
| Abbott | 1 | $25 |
| Merck | 1 | $22 |
| Novo Nordisk | 1 | $19 |
| Lilly USA, LLC | 1 | $19 |
| VBI Vaccine (delaware) Inc. | 1 | $17 |
| AstraZeneca | 1 | $11 |
| Sanofi-aventis U.S. LLC | 1 | $11 |
How this compares
$353,563 in reported general payments places this provider in the 95th percentile of 2,087 family medicine providers in Tennessee.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| TrulicityDulaglutide | 36 | $43,600 |
| FarxigaDapagliflozin Propanediol | 29 | $43,458 |
| JanuviaSitagliptin Phosphate | 32 | $28,143 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 12 | $8,487 |
| Tresiba Flextouch U-100Insulin Degludec | 22 | $8,478 |
| Insulin Lispro Kwikpen U-100Insulin Lispro | 21 | $4,653 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 30 | $4,145 |
| SymbicortBudesonide/Formoterol Fumarate | 11 | $2,832 |
| LantusInsulin Glargine,hum.Rec.Anlog | 17 | $1,906 |
| Atorvastatin Calcium | 166 | $1,504 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 52 | $1,500 |
| Losartan Potassium | 120 | $1,080 |
| Celecoxib | 22 | $799 |
| Methocarbamol | 43 | $770 |
| Hydralazine Hcl | 54 | $708 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AstraZenecaFarxiga, Symbicort | $11 | $46,29040 claims |
| Lilly USA, LLCTrulicity | $19 | $43,60036 claims |
| MerckJanuvia | $22 | $28,14332 claims |
| GSKTrelegy Ellipta | $76 | $8,48712 claims |
| Sanofi-aventis U.S. LLCLantus | $11 | $1,90617 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 2,087 family medicine providers in Tennessee.
Other family medicine in Franklin
- Charolette JacksonBartlett$162K
- Keren HolmesNashville$58K
- Kabir Harricharan SinghNewport$49K
- Khaisha GistAntioch$49K
- Jerry PunchKnoxville$45K
- Christopher HollowayAntioch$41K
- Curtis JantziKingsport$39K
- Ellen ClelandChattanooga$38K
- Meredith SchweitzerAntioch$37K
- Jason GoolsbyBrownsville$37K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.